Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
SH Michaels, R Clark, P Kissinger - New England Journal of …, 1998 - Mass Medical Soc
SH Michaels, R Clark, P Kissinger
New England Journal of Medicine, 1998•Mass Medical SocTo the Editor: Palella et al.(March 26 issue) 1 reported that the use of more intensive
antiretroviral therapies is responsible for declines in both morbidity and mortality in patients
with AIDS. We conducted a study to evaluate the impact of protease inhibitors on the rates of
selected opportunistic processes and mortality and found similar results. Our study
population came from a public human immunodeficiency virus (HIV) outpatient clinic in New
Orleans. All subjects and data were from the Adult Spectrum of Disease study, a prospective …
antiretroviral therapies is responsible for declines in both morbidity and mortality in patients
with AIDS. We conducted a study to evaluate the impact of protease inhibitors on the rates of
selected opportunistic processes and mortality and found similar results. Our study
population came from a public human immunodeficiency virus (HIV) outpatient clinic in New
Orleans. All subjects and data were from the Adult Spectrum of Disease study, a prospective …
To the Editor: Palella et al. (March 26 issue)1 reported that the use of more intensive antiretroviral therapies is responsible for declines in both morbidity and mortality in patients with AIDS. We conducted a study to evaluate the impact of protease inhibitors on the rates of selected opportunistic processes and mortality and found similar results.
Our study population came from a public human immunodeficiency virus (HIV) outpatient clinic in New Orleans. All subjects and data were from the Adult Spectrum of Disease study, a prospective study funded by the Centers for Disease Control and Prevention examining the natural history of . . .
The New England Journal Of Medicine